Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMartin Currie Global Portfolio Trust Regulatory News (MNP)

Share Price Information for Martin Currie Global Portfolio Trust (MNP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 369.00
Bid: 369.00
Ask: 370.00
Change: 4.00 (1.10%)
Spread: 1.00 (0.271%)
Open: 366.00
High: 370.00
Low: 366.00
Prev. Close: 365.00
MNP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

1 Jun 2023 13:36

RNS Number : 3796B
Martin Currie Global Portfolio Tst
01 June 2023
 

Martin Currie Global Portfolio Trust plc

Legal Entity Identifier: 549300RKB85NFVSTBM94

Results of Annual General Meeting

The Annual General Meeting of the Company was held at 11.00am on Thursday 1 June 2023. The following resolutions, as set out in the Notice of Annual General Meeting were duly passed. Resolutions numbered 1 to 11 were passed as ordinary resolutions and resolutions 12 to 15 were passed as special resolutions.

 

Ordinary business

Ordinary resolutions

 

1. That the Report of the directors and auditors and the financial statements for the year ended 31 January 2023 be received.

 

2. That the Directors' annual remuneration report for the year ended 31 January 2023 be approved;

 

3. That the Directors' remuneration policy be approved;

 

4. That the dividend policy be approved;

 

5. That Marian Glen be re-elected as a Director;

 

6. That Gary Le Sueur be re-elected as a Director;

 

7. That Christopher Metcalfe be re-elected as a Director;

 

8. That Lindsay Dodsworth be re-elected as a Director;

 

9. That Ernst & Young LLP be re-appointed as auditors of the Company to hold office from the conclusion of this meeting until the conclusion of the next general meeting at which accounts are laid before the Company;

 

10. That the Directors be authorised to fix the remuneration of the auditors for the year ending 31 January 2024;

 

11. That, in substitution for any existing authority, the directors of the Company be and are hereby generally and

unconditionally authorised pursuant to s551 of the Companies Act 2006 (the 'Act') to allot equity securities (as defined in s560 of the Act) up to a maximum nominal amount of £1,239,443 (being approximately one third of the issued share capital of the Company (excluding Treasury shares) as at 31 March 2023, being the latest practicable date before the date of this notice) provided that the authority hereby given shall expire on 31 July 2024 or, if earlier, the conclusion of the annual general meeting of the Company in 2024 save that the Company may, at any time before the expiry of such authority, make an offer or enter into an agreement which would or might require equity securities to be allotted after the expiry of such authority and the directors may allot equity securities in pursuance of such an offer or agreement as if such authority had not expired.

 

Special business

Special resolutions

 

12. That, pursuant to Article 12 of the Articles of Association of the Company and in accordance with s701 of the Companies Act 2006 (the 'Act') and in substitution for any existing authority, the Company be and is hereby generally and unconditionally authorised to make market purchases (within the meaning of s693(4) of the Act) of Ordinary shares of 5 pence each in the capital of the Company provided that:

(a) the maximum aggregate number of Ordinary shares hereby authorised to be purchased is 11,147,557 (or, if less, 14.99% of the number of Ordinary shares in issue (excluding Treasury shares) immediately prior to the passing of this resolution);

(b) the minimum price which may be paid for an Ordinary share is 5 pence (exclusive of expenses);

(c) the maximum price (exclusive of expenses) which may be paid for an Ordinary share shall be not more than the higher of

(i) 5% above the average of the mid-market quotations for an Ordinary share of the Company as derived from the Daily Official List of the London Stock Exchange for the five business days immediately preceding the date of purchase; and

(ii) the higher of the last independent trade and the highest current independent bid on the London Stock Exchange;

(d) the authority hereby conferred shall expire 15 months after the date of passing of this resolution or, if earlier, at the conclusion of the AGM of the Company in 2024, unless such authority is renewed, issued or revoked prior to such time; and

(e) the Company may conclude a contract to purchase Ordinary shares under the authority hereby conferred prior to the expiry of such authority which will or may be executed wholly or partly after the expiry of such authority and may make a purchase of Ordinary shares in pursuance of any such contract as if the authority hereby confirmed had not expired.

 

13. That the Directors be and they are hereby empowered in accordance with s570 and s573 of the Companies Act 2006 (the 'Act') to allot equity securities (as defined in s560 of the Act), where they are generally authorised pursuant to the authority to allot equity securities conferred upon them by resolution 11 and/or to sell Ordinary shares held by the Company as Treasury shares, for cash, as if s561 of the Act did not apply provided that the power conferred by this resolution shall be limited to the allotment of equity securities having a nominal amount not exceeding in aggregate £371,833 (being an amount equal to 10% of issued equity share capital (excluding Treasury shares) as at 31 March 2023 being the latest practicable date before the date of this notice). Unless previously varied, revoked or renewed, the authority hereby conferred shall expire on 31 July 2024 or, if earlier at the conclusion of the annual general meeting of the Company in 2024, save that the Company may, before the expiry of any power contained in this resolution, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the directors may allot equity securities in pursuance of such an offer or agreement as if the power conferred hereby had not expired.

 

14. That, in addition to any authority granted under resolution 15, the Directors be and they are hereby empowered in accordance with s570 and s573 of the Companies Act 2006 (the 'Act') to allot equity securities (as defined in s560 of the Act), where they are generally authorised pursuant to the authority to allot equity securities conferred upon them by resolution 11 and/or to sell Ordinary shares held by the Company as Treasury shares, for cash, as if s561 of the Act did not apply provided that the power conferred by this resolution shall be limited to the further allotment of equity securities having a nominal amount not exceeding in aggregate £371,833 (being an amount equal to 10% of issued equity share capital (excluding Treasury shares) as at 31 March 2023 being the latest practicable date before the date of this notice).

Unless previously varied, revoked or renewed, the authority hereby conferred shall expire on 31 July 2024 or, if earlier, at the conclusion of the annual general meeting of the Company in 2024, save that the Company may, before the expiry of any power contained in this resolution, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the directors may allot equity securities in pursuance of such an offer or agreement as if the power conferred hereby had not expired.

 

15. That a general meeting, other than an annual general meeting, may be called on not less than 14 clear days' notice. Unless previously varied, revoked or renewed, the authority hereby conferred shall expire on 31 July 2024 or, if earlier, at the conclusion of the annual general meeting of the Company in 2024.

 

 

Proxy votes cast were as follows:

For and Discretion

Against

Withheld

Resolution

Votes

%

Votes

%

1

To receive the report of the directors and auditors and the financial statements for the year ended 31 January 2023

17,919,653

100.00

799

0.00

0

2

To approve the directors' remuneration report for the year ended 31 January 2023

17,450,273

99.60

70,403

0.40

399,776

3

To approve the directors' remuneration policy

17,443,512

99.54

81,226

0.46

395,714

4

To approve the dividend policy

17,457,908

99.39

106,812

0.61

355,732

5

To re-elect Marian Glen as a director

17,001,595

 

96.87

549,109

3.13

369,748

6

To re-elect Gary Le Sueur as a director

16,930,872

96.47

619,832

3.53

369,748

7

To re-elect Christopher Metcalfe as a director

17,017,586

96.98

530,605

3.02

372,261

8

To re-elect Lindsay Dodsworth as a director

17,001,595

96.89

546,596

3.11

372,261

9

To re-appoint Ernst & Young LLP as auditors

17,536,027

99.76

41,912

0.24

342,513

10

To authorise the directors to fix the remuneration of the auditors for the year ending 31 January 2024

17,569,258

99.95

8,681

0.05

342,513

11

To give authority to allot shares

17,522,320

99.74

46,256

0.26

351,876

12

To give authority for share buybacks

16,427,151

91.72

1,483,862

8.28

9,439

13

To give authority to disapply pre-emption rights

17,451,537

99.44

98,612

0.56

370,303

14

To give authority to disapply pre-emption rights to a further 10%

17,387,330

99.03

170,768

0.97

362,354

15

To give authority for general meetings to be held on 14 clear days' notice

17,483,620

99.46

95,073

0.54

341,759

 

 

Franklin Templeton Investment Trust Management Limited

Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSLFEFEDSEDM
Date   Source Headline
3rd May 20244:48 pmRNSTransaction in Own Shares
3rd May 20248:47 amRNSNet Asset Value(s)
2nd May 20244:48 pmRNSTransaction in Own Shares
2nd May 20249:28 amRNSNet Asset Value(s)
1st May 20244:44 pmRNSTransaction in Own Shares
1st May 202411:07 amRNSQuarterly disclosure
1st May 202410:18 amRNSNet Asset Value(s)
1st May 20249:45 amRNSTotal Voting Rights
30th Apr 20244:51 pmRNSTransaction in Own Shares
30th Apr 20249:05 amRNSNet Asset Value(s)
29th Apr 20244:46 pmRNSTransaction in Own Shares
29th Apr 202410:11 amRNSNet Asset Value(s)
26th Apr 20244:45 pmRNSTransaction in Own Shares
26th Apr 20248:39 amRNSNet Asset Value(s)
25th Apr 20248:52 amRNSNet Asset Value(s)
24th Apr 20244:52 pmRNSTransaction in Own Shares
24th Apr 20249:12 amRNSChange of director details
24th Apr 20248:40 amRNSNet Asset Value(s)
23rd Apr 20245:21 pmRNSFinal Results
23rd Apr 20244:45 pmRNSTransaction in Own Shares
23rd Apr 20249:27 amRNSNet Asset Value(s)
22nd Apr 20244:54 pmRNSTransaction in Own Shares
22nd Apr 20248:47 amRNSNet Asset Value(s)
19th Apr 20244:52 pmRNSTransaction in Own Shares
19th Apr 20248:48 amRNSNet Asset Value(s)
18th Apr 20244:47 pmRNSTransaction in Own Shares
18th Apr 20248:55 amRNSNet Asset Value(s)
17th Apr 20244:46 pmRNSTransaction in Own Shares
17th Apr 20249:04 amRNSNet Asset Value(s)
16th Apr 20244:44 pmRNSTransaction in Own Shares
16th Apr 20248:37 amRNSNet Asset Value(s)
15th Apr 20244:50 pmRNSTransaction in Own Shares
15th Apr 20249:03 amRNSNet Asset Value(s)
12th Apr 20244:52 pmRNSTransaction in Own Shares
12th Apr 20249:06 amRNSNet Asset Value(s)
11th Apr 20244:51 pmRNSTransaction in Own Shares
11th Apr 20248:43 amRNSNet Asset Value(s)
10th Apr 20244:46 pmRNSTransaction in Own Shares
10th Apr 20248:52 amRNSNet Asset Value(s)
9th Apr 20244:51 pmRNSTransaction in Own Shares
9th Apr 20248:52 amRNSNet Asset Value(s)
8th Apr 20244:55 pmRNSTransaction in Own Shares
8th Apr 20248:48 amRNSNet Asset Value(s)
5th Apr 20248:47 amRNSNet Asset Value(s)
4th Apr 20244:50 pmRNSTransaction in Own Shares
4th Apr 20248:44 amRNSNet Asset Value(s)
3rd Apr 20244:48 pmRNSTransaction in Own Shares
3rd Apr 20249:16 amRNSNet Asset Value(s)
2nd Apr 20244:50 pmRNSTransaction in Own Shares
2nd Apr 20247:59 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.